Global Cell and Gene Therapy Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Description

The global Cell and Gene Therapy Drug Delivery Devices market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Cell and gene therapy drug delivery industry is a transformative industry whose full potential is only just beginning to emerge. Cell and gene therapy involves the extraction of cells, protein, or genetic material (DNA) from the donor, and altering them to provide highly personalized therapy. Cell and gene therapies may offer longer-lasting effects than traditional medicines. One of the significant drugs of the cell and gene therapy industry is CAR-T cell-based medicines, which include both cell therapy and gene therapy. Various market players are actively investing in the research and development of the cell and gene therapy industry. The players are offering improved and new products, which meet the critical needs of patients.

This report studies the global Cell and Gene Therapy Drug Delivery Devices demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Drug Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Drug Delivery Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Drug Delivery Devices total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy Drug Delivery Devices total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices revenue by player and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy Drug Delivery Devices total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy Drug Delivery Devices market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Inc., Bausch and Lomb Incorporated, Becton, Dickinson and Company, Bluebird bio, Inc., Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), Dendreon Pharmaceuticals LLC., Helixmith Co., Ltd (ViroMed Co., Ltd), Human Stem Cell Institute and Kite Pharma, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Drug Delivery Devices market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy Drug Delivery Devices Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Drug Delivery Devices Market, Segmentation by Type
    Sterile Insulin Syringe
    Pre-Filled Syringe
    Infusion Bags

Global Cell and Gene Therapy Drug Delivery Devices Market, Segmentation by Application
    Luxturna
    Kymriah
    Provenge
    Zolgensma
    Yescarta
    Strimvelis

Companies Profiled:
    Amgen, Inc.
    Bausch and Lomb Incorporated
    Becton, Dickinson and Company
    Bluebird bio, Inc.
    Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
    Dendreon Pharmaceuticals LLC.
    Helixmith Co., Ltd (ViroMed Co., Ltd)
    Human Stem Cell Institute
    Kite Pharma, Inc.
    Kolon Tissue Gene, inc.
    Novartis AG
    Orchard Therapeutics plc.
    Pfizer, Inc.
    Renova Therapeutics
    Spark Therapeutics, Inc.
    uniQure N.V.
    Vericel Corporation

Key Questions Answered
1. How big is the global Cell and Gene Therapy Drug Delivery Devices market?
2. What is the demand of the global Cell and Gene Therapy Drug Delivery Devices market?
3. What is the year over year growth of the global Cell and Gene Therapy Drug Delivery Devices market?
4. What is the total value of the global Cell and Gene Therapy Drug Delivery Devices market?
5. Who are the major players in the global Cell and Gene Therapy Drug Delivery Devices market?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Drug Delivery Devices Introduction
    1.2 World Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy Drug Delivery Devices Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.3 China Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.5 Japan Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.6 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.7 ASEAN Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
        1.3.8 India Cell and Gene Therapy Drug Delivery Devices Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Drug Delivery Devices Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Drug Delivery Devices Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030)

3 World Cell and Gene Therapy Drug Delivery Devices Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Drug Delivery Devices Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Drug Delivery Devices Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Drug Delivery Devices in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Drug Delivery Devices in 2023
    3.3 Cell and Gene Therapy Drug Delivery Devices Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Drug Delivery Devices Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Drug Delivery Devices Market: Region Footprint
        3.4.2 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy Drug Delivery Devices Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy Drug Delivery Devices Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Drug Delivery Devices Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Sterile Insulin Syringe
        5.2.2 Pre-Filled Syringe
        5.2.3 Infusion Bags
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Drug Delivery Devices Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Luxturna
        6.2.2 Kymriah
        6.2.3 Provenge
        6.2.4 Zolgensma
        6.2.5 Zolgensma
        6.2.6 Strimvelis
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Amgen, Inc.
        7.1.1 Amgen, Inc. Details
        7.1.2 Amgen, Inc. Major Business
        7.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Amgen, Inc. Recent Developments/Updates
        7.1.6 Amgen, Inc. Competitive Strengths & Weaknesses
    7.2 Bausch and Lomb Incorporated
        7.2.1 Bausch and Lomb Incorporated Details
        7.2.2 Bausch and Lomb Incorporated Major Business
        7.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Bausch and Lomb Incorporated Recent Developments/Updates
        7.2.6 Bausch and Lomb Incorporated Competitive Strengths & Weaknesses
    7.3 Becton, Dickinson and Company
        7.3.1 Becton, Dickinson and Company Details
        7.3.2 Becton, Dickinson and Company Major Business
        7.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Becton, Dickinson and Company Recent Developments/Updates
        7.3.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
    7.4 Bluebird bio, Inc.
        7.4.1 Bluebird bio, Inc. Details
        7.4.2 Bluebird bio, Inc. Major Business
        7.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Bluebird bio, Inc. Recent Developments/Updates
        7.4.6 Bluebird bio, Inc. Competitive Strengths & Weaknesses
    7.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
        7.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details
        7.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
        7.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments/Updates
        7.5.6 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Competitive Strengths & Weaknesses
    7.6 Dendreon Pharmaceuticals LLC.
        7.6.1 Dendreon Pharmaceuticals LLC. Details
        7.6.2 Dendreon Pharmaceuticals LLC. Major Business
        7.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Dendreon Pharmaceuticals LLC. Recent Developments/Updates
        7.6.6 Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    7.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
        7.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Details
        7.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
        7.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments/Updates
        7.7.6 Helixmith Co., Ltd (ViroMed Co., Ltd) Competitive Strengths & Weaknesses
    7.8 Human Stem Cell Institute
        7.8.1 Human Stem Cell Institute Details
        7.8.2 Human Stem Cell Institute Major Business
        7.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Human Stem Cell Institute Recent Developments/Updates
        7.8.6 Human Stem Cell Institute Competitive Strengths & Weaknesses
    7.9 Kite Pharma, Inc.
        7.9.1 Kite Pharma, Inc. Details
        7.9.2 Kite Pharma, Inc. Major Business
        7.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Kite Pharma, Inc. Recent Developments/Updates
        7.9.6 Kite Pharma, Inc. Competitive Strengths & Weaknesses
    7.10 Kolon Tissue Gene, inc.
        7.10.1 Kolon Tissue Gene, inc. Details
        7.10.2 Kolon Tissue Gene, inc. Major Business
        7.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Kolon Tissue Gene, inc. Recent Developments/Updates
        7.10.6 Kolon Tissue Gene, inc. Competitive Strengths & Weaknesses
    7.11 Novartis AG
        7.11.1 Novartis AG Details
        7.11.2 Novartis AG Major Business
        7.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Novartis AG Recent Developments/Updates
        7.11.6 Novartis AG Competitive Strengths & Weaknesses
    7.12 Orchard Therapeutics plc.
        7.12.1 Orchard Therapeutics plc. Details
        7.12.2 Orchard Therapeutics plc. Major Business
        7.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Orchard Therapeutics plc. Recent Developments/Updates
        7.12.6 Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    7.13 Pfizer, Inc.
        7.13.1 Pfizer, Inc. Details
        7.13.2 Pfizer, Inc. Major Business
        7.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Pfizer, Inc. Recent Developments/Updates
        7.13.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.14 Renova Therapeutics
        7.14.1 Renova Therapeutics Details
        7.14.2 Renova Therapeutics Major Business
        7.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Renova Therapeutics Recent Developments/Updates
        7.14.6 Renova Therapeutics Competitive Strengths & Weaknesses
    7.15 Spark Therapeutics, Inc.
        7.15.1 Spark Therapeutics, Inc. Details
        7.15.2 Spark Therapeutics, Inc. Major Business
        7.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Spark Therapeutics, Inc. Recent Developments/Updates
        7.15.6 Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    7.16 uniQure N.V.
        7.16.1 uniQure N.V. Details
        7.16.2 uniQure N.V. Major Business
        7.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 uniQure N.V. Recent Developments/Updates
        7.16.6 uniQure N.V. Competitive Strengths & Weaknesses
    7.17 Vericel Corporation
        7.17.1 Vericel Corporation Details
        7.17.2 Vericel Corporation Major Business
        7.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Services
        7.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Vericel Corporation Recent Developments/Updates
        7.17.6 Vericel Corporation Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Drug Delivery Devices Industry Chain
    8.2 Cell and Gene Therapy Drug Delivery Devices Upstream Analysis
    8.3 Cell and Gene Therapy Drug Delivery Devices Midstream Analysis
    8.4 Cell and Gene Therapy Drug Delivery Devices Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cell and Gene Therapy Drug Delivery Devices Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cell and Gene Therapy Drug Delivery Devices Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Drug Delivery Devices Players in 2023
    Table 12. World Cell and Gene Therapy Drug Delivery Devices Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cell and Gene Therapy Drug Delivery Devices Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Drug Delivery Devices Player
    Table 15. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Drug Delivery Devices Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Drug Delivery Devices Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Drug Delivery Devices Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Drug Delivery Devices Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2019-2024)
    Table 23. China Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cell and Gene Therapy Drug Delivery Devices Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Drug Delivery Devices Revenue Market Share (2019-2024)
    Table 29. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2025-2030) & (USD Million)
    Table 35. Amgen, Inc. Basic Information, Area Served and Competitors
    Table 36. Amgen, Inc. Major Business
    Table 37. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 38. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Amgen, Inc. Recent Developments/Updates
    Table 40. Amgen, Inc. Competitive Strengths & Weaknesses
    Table 41. Bausch and Lomb Incorporated Basic Information, Area Served and Competitors
    Table 42. Bausch and Lomb Incorporated Major Business
    Table 43. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 44. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Bausch and Lomb Incorporated Recent Developments/Updates
    Table 46. Bausch and Lomb Incorporated Competitive Strengths & Weaknesses
    Table 47. Becton, Dickinson and Company Basic Information, Area Served and Competitors
    Table 48. Becton, Dickinson and Company Major Business
    Table 49. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 50. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Becton, Dickinson and Company Recent Developments/Updates
    Table 52. Becton, Dickinson and Company Competitive Strengths & Weaknesses
    Table 53. Bluebird bio, Inc. Basic Information, Area Served and Competitors
    Table 54. Bluebird bio, Inc. Major Business
    Table 55. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 56. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Bluebird bio, Inc. Recent Developments/Updates
    Table 58. Bluebird bio, Inc. Competitive Strengths & Weaknesses
    Table 59. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Basic Information, Area Served and Competitors
    Table 60. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business
    Table 61. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 62. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments/Updates
    Table 64. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Competitive Strengths & Weaknesses
    Table 65. Dendreon Pharmaceuticals LLC. Basic Information, Area Served and Competitors
    Table 66. Dendreon Pharmaceuticals LLC. Major Business
    Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 68. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Dendreon Pharmaceuticals LLC. Recent Developments/Updates
    Table 70. Dendreon Pharmaceuticals LLC. Competitive Strengths & Weaknesses
    Table 71. Helixmith Co., Ltd (ViroMed Co., Ltd) Basic Information, Area Served and Competitors
    Table 72. Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business
    Table 73. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 74. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments/Updates
    Table 76. Helixmith Co., Ltd (ViroMed Co., Ltd) Competitive Strengths & Weaknesses
    Table 77. Human Stem Cell Institute Basic Information, Area Served and Competitors
    Table 78. Human Stem Cell Institute Major Business
    Table 79. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 80. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Human Stem Cell Institute Recent Developments/Updates
    Table 82. Human Stem Cell Institute Competitive Strengths & Weaknesses
    Table 83. Kite Pharma, Inc. Basic Information, Area Served and Competitors
    Table 84. Kite Pharma, Inc. Major Business
    Table 85. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 86. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Kite Pharma, Inc. Recent Developments/Updates
    Table 88. Kite Pharma, Inc. Competitive Strengths & Weaknesses
    Table 89. Kolon Tissue Gene, inc. Basic Information, Area Served and Competitors
    Table 90. Kolon Tissue Gene, inc. Major Business
    Table 91. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 92. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Kolon Tissue Gene, inc. Recent Developments/Updates
    Table 94. Kolon Tissue Gene, inc. Competitive Strengths & Weaknesses
    Table 95. Novartis AG Basic Information, Area Served and Competitors
    Table 96. Novartis AG Major Business
    Table 97. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 98. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Novartis AG Recent Developments/Updates
    Table 100. Novartis AG Competitive Strengths & Weaknesses
    Table 101. Orchard Therapeutics plc. Basic Information, Area Served and Competitors
    Table 102. Orchard Therapeutics plc. Major Business
    Table 103. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 104. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Orchard Therapeutics plc. Recent Developments/Updates
    Table 106. Orchard Therapeutics plc. Competitive Strengths & Weaknesses
    Table 107. Pfizer, Inc. Basic Information, Area Served and Competitors
    Table 108. Pfizer, Inc. Major Business
    Table 109. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 110. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Pfizer, Inc. Recent Developments/Updates
    Table 112. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 113. Renova Therapeutics Basic Information, Area Served and Competitors
    Table 114. Renova Therapeutics Major Business
    Table 115. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 116. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Renova Therapeutics Recent Developments/Updates
    Table 118. Renova Therapeutics Competitive Strengths & Weaknesses
    Table 119. Spark Therapeutics, Inc. Basic Information, Area Served and Competitors
    Table 120. Spark Therapeutics, Inc. Major Business
    Table 121. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 122. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Spark Therapeutics, Inc. Recent Developments/Updates
    Table 124. Spark Therapeutics, Inc. Competitive Strengths & Weaknesses
    Table 125. uniQure N.V. Basic Information, Area Served and Competitors
    Table 126. uniQure N.V. Major Business
    Table 127. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 128. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. uniQure N.V. Recent Developments/Updates
    Table 130. Vericel Corporation Basic Information, Area Served and Competitors
    Table 131. Vericel Corporation Major Business
    Table 132. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Services
    Table 133. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 134. Global Key Players of Cell and Gene Therapy Drug Delivery Devices Upstream (Raw Materials)
    Table 135. Cell and Gene Therapy Drug Delivery Devices Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture
    Figure 2. World Cell and Gene Therapy Drug Delivery Devices Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cell and Gene Therapy Drug Delivery Devices Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Drug Delivery Devices Revenue (2019-2030) & (USD Million)
    Figure 13. Cell and Gene Therapy Drug Delivery Devices Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cell and Gene Therapy Drug Delivery Devices Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Drug Delivery Devices by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Drug Delivery Devices Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Drug Delivery Devices Markets in 2023
    Figure 27. United States VS China: Cell and Gene Therapy Drug Delivery Devices Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cell and Gene Therapy Drug Delivery Devices Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cell and Gene Therapy Drug Delivery Devices Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type in 2023
    Figure 31. Sterile Insulin Syringe
    Figure 32. Pre-Filled Syringe
    Figure 33. Infusion Bags
    Figure 34. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Type (2019-2030)
    Figure 35. World Cell and Gene Therapy Drug Delivery Devices Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Cell and Gene Therapy Drug Delivery Devices Market Size Market Share by Application in 2023
    Figure 37. Luxturna
    Figure 38. Kymriah
    Figure 39. Provenge
    Figure 40. Zolgensma
    Figure 41. Yescarta
    Figure 42. Strimvelis
    Figure 43. Cell and Gene Therapy Drug Delivery Devices Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

Amgen, Inc.
Bausch and Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio, Inc.
Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
Dendreon Pharmaceuticals LLC.
Helixmith Co., Ltd (ViroMed Co., Ltd)
Human Stem Cell Institute
Kite Pharma, Inc.
Kolon Tissue Gene, inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer, Inc.
Renova Therapeutics
Spark Therapeutics, Inc.
uniQure N.V.
Vericel Corporation